Praxis Precision Medicines
Nasdaq PRAX · Boston, MA
Works in Neurology · Psychiatry
Praxis Precision Medicines is a clinical trial sponsor based in Boston, MA, listed as Nasdaq PRAX. It has 8 active clinical trials with 2,387 planned participants, in Neurology and Psychiatry. Since 2021 it has completed 7 trials and stopped 2 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq PRAX
Fundraising
Pipeline · 8 active trials
| Stage | Trial | Status |
|---|---|---|
On the market · 0 products
No marketed products under this name.
Questions about Praxis Precision Medicines
No warning letter naming Praxis Precision Medicines is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Praxis Precision Medicines. The latest inspection ended on 2026-07-10 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Praxis Precision Medicines is lead sponsor of 8 active clinical trials on ClinicalTrials.gov, with 2,387 planned participants, in Neurology, Psychiatry. Since 2021 it has completed 7 trials and stopped 2 early.
Praxis Precision Medicines is based in Boston, MA and is listed as Nasdaq PRAX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Praxis Precision Medicines; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-06.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-25.
Approve Suite is not affiliated with Praxis Precision Medicines.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.